CABERGOLINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia. (Chemical Entities of Biological Interest Ontology, CHEBI_3286)
External Link https://dgidb.org/results?searchType=drug&searchTerms=CABERGOLINE
Similar Terms
Downloads & Tools

Genes

15 interacting proteins for the CABERGOLINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
DRD5 dopamine receptor D5 0.084019
DRD2 dopamine receptor D2 0.0794775
DRD4 dopamine receptor D4 0.0446683
ADRA2B adrenoceptor alpha 2B 0.038778
HTR1D 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 0.0345961
HTR1B 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 0.0329794
DRD3 dopamine receptor D3 0.0301607
HTR2B 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled 0.0299051
ADRA2A adrenoceptor alpha 2A 0.0299051
ADRA2C adrenoceptor alpha 2C 0.0286894
ADRA1A adrenoceptor alpha 1A 0.025387
HTR2C 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled 0.0243365
HTR1A 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 0.0210048
DRD1 dopamine receptor D1 0.019389
HTR2A 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 0.0161872